Eli Lilly plans to acquire Centessa Pharmaceuticals, which has been conducting a midstage clinical trial of its lead drug.
Business
·
Eli Lilly Will Buy a Narcolepsy Drug Developer for $6.3 Billion
CN
CitrixNews Staff
Originally reported by New York Times
Related Articles
Business
Global Ban on Digital Duties Expires After Stalled Talks at W.T.O.
A prohibition on taxing digital downloads expired, after members of the World Trade Organization concluded their annual ...
CitrixNews Staff
·
1 hour ago
Business
Lilly to spend up to $7.8 billion to acquire Centessa, a maker of experimental sleep disorder drugs
Eli Lilly has agreed to pay up to $7.8 billion to acquire Centessa Pharmaceuticals and its experimental drug for excessi...
CitrixNews Staff
·
1 hour ago
Business
Denby appoints administrators in 'necessary step'
Denby appoints administrators in 'necessary step'18 minutes agoShareSaveAdd as preferred on GoogleLaura Hammon...
CitrixNews Staff
·
2 hours ago
Business
'Project Hail Mary' is the box office proof point Amazon MGM has been waiting for
"Project Hail Mary" is setting records for Amazon MGM and lighting the path for a box-office revitalization. T...
CitrixNews Staff
·
2 hours ago